Next Generation Transcatheter Aortic Valve Systems: the PorticoTM Valve

Authors

  • Apostolos Tzikas 1.Interbalkan European Medical Center, Thessaloniki, Greece, 2.Hygeia Hospital, Athens, Greece
  • Michael Chrissoheris Hygeia Hospital, Athens, Greece
  • Antonis Halapas Hygeia Hospital, Athens, Greece
  • Konstantinos Spargias Hygeia Hospital, Athens, Greece

DOI:

https://doi.org/10.2015/hc.v9i1%20Sup.660

Keywords:

aortic stenosis, Aortic valve, aortic valve replacement, ta vi, TAVR

Abstract

Transcatheter aortic valve replacement (TAVR) is currently considered a valuable alternative for the treatment of severe symptomatic aortic stenosis patients who are inoperable or at excessively high surgical risk.

Downloads

Published

2014-06-02

Issue

Vol. 9 No. 1 Sup (2014): ATHENS CARDIOLOGY UPDATE 2014

Section

ATHENS CARDIOLOGY UPDATE 2014

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).